Three persons, three genetic contributors, three parents: Mitochondrial donation, genetic parenting and the immutable grammar of the ‘three x x’ by Dimond, B & Stephens, NS
1 
 
Three persons, three genetic contributors, three parents: Mitochondrial donation, 
genetic parenting and the immutable grammar of the ‘three x x’. 
 
Abstract 
In 2015 two novel in vitro fertilisation (IVF) techniques intended to prevent the 
inheritance of mitochondrial disease were legalised in the United Kingdom, 
following an intense period of inquiry including scientific reviews, public 
consultations, government guidance and debates within the Houses of 
Parliament. The techniques were controversial because (i) they introduced a third 
genetic contributor into the reproductive process and (ii) they are germ-line, 
meaning this genetic change could then be passed down to subsequent 
generations. Drawing on the social worlds framework with a focus on implicated 
actors and discursive strategies, this article explores key features of the UK 
mitochondrial debates as they played out in real time through policy documents 
and public debate. First of all it situates the technology within a repertoire of 
metaphors, emotional terminology and their politics. It then explores the 
immutable grammar of ‘three x x’ that formed a key component of the political 
debate, by focusing on how institutional reviews discursively negotiated 
uncertainty around genetic parentage and how beneficiaries were implicated and 
rendered distant. Following the 2016 announcement of the first baby born 
through mitochondrial donation (in Mexico) and several pregnancies (in the 
Ukraine), we close with a discussion about the specific nature of UK regulation 
within a global economy. Overall, this article contributes to a much needed 
sociological discussion about mitochondrial donation, emerging reproductive 
technologies and the cultural significance of genetic material and genetic 
relatedness.  
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Introduction 
In 2015 the UK Parliament approved the clinical application of the novel in vitro 
fertilisation (IVF) procedures ‘maternal spindle transfer’ and ‘pro-nuclear transfer’ 
after an extensive process of scientific and ethical review, and public consultation. 
In this article we analyse the political debates in the UK that led to the first 
national regulations permitting mitochondrial donation as they played out in real 
time through policy documents and public debate. The techniques, known as 
‘mitochondrial donation’ or ‘mitochondrial transfer’, used part of a donated egg 
to enable a woman with mitochondrial disease to have a healthy, genetically 
related child. Significant features of these techniques, and the reason why they 
have attracted such intense ethical enquiry are (i) they involved a third genetic 
contributor within the reproductive process in the form of the mitochondrial 
donor, and (ii) they are germline technologies in that the donor’s genetic material 
can be passed on through the generations.  
Mitochondria are small structures in the cytoplasm of a cell which 
produce the cell’s energy and can cause mitochondrial disease when they fail to 
function (for an overview of the history of mitochondrial diseases, see DiMauro, 
2011). Women with faults in their mitochondrial DNA will pass these on to their 
children, which means that both sexes can inherit the disease from their own 
mothers, but only women are at risk of having a child who also has the disease 
(Poulton et al., 2010). There is no cure for mitochondrial disease and as treatment 
options are currently limited, attention has turned to reproductive intervention.  
 
Mitochondrial donation and the role of the donor 
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The two IVF technologies that have now been legalised in the UK could allow a 
woman with mitochondrial disease to have a child without the risk of passing on 
the disease. Maternal spindle transfer involved removing the nucleus of the egg 
and placing it into a donated, enucleated egg. Pro-nuclear transfer, which has 
been developed by the Wellcome Trust Centre for Mitochondrial Research in 
Newcastle (UK), involved a similar process but occured after fertilisation (for a 
technical overview of the techniques see Amato et al., 2014; Herbert and 
Turnbull, 2015; for a review of the ethical distinction between the two techniques 
see Wrigley et al., 2015).  
Mitochondria contain genetic material, so any child born through the 
techniques would inherit nuclear genes from the intended mother and father and 
mitochondrial genes from the mitochondrial donor. As Richards (2014) describes, 
the inclusion of others in the reproductive process, as a collaborative enterprise, 
is not necessarily a new phenomenon. Richards et al. (2012: 1) highlight that up to 
five progenitors had been possible: ‘a social mother, a social father, a biological 
father (sperm provider), a biological mother (egg provider) and a surrogate 
(gestational mother)’. The mitochondrial donor can now be added as the sixth. 
However, the mitochondrial donor presents us with an interesting categorical 
challenge because along with the biological father and biological mother, she is 
also a genetic contributor.  
The techniques were first developed more than ten years ago, and the 
law amended within the UK in 2008 to allow for the future possibility of 
legalisation (Jones and Holme, 2013). Across this period the presence and role of 
this ‘third person’ remained the primary focus of debate. Questions included the 
social and legal status of the relationship between child and donor (Bredenoord et 
al., 2008; McCanless and Sheldon, 2014) and the potential impact on the child and 
their sense of self (Baylis, 2013; McLean, 2015). Furthermore, this led to 
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ontological questions, including what is identity, what is a parent and what is 
genetic relatedness. In sum, much of the debates about mitochondrial donation 
can be characterised by competing perspectives about the biological and social 
significance of the mitochondrial donor and her imagined role in the life of the 
child.  
 
Mitochondrial donation and UK biomedical culture 
The second feature of mitochondrial donation, and possibly the most important in 
terms of legal requirements, is that it involves modification of the germ line. This 
means that if the child is female, her children will also inherit the donor’s 
mitochondrial DNA. Because of this, a positive vote was required in both UK 
Houses of Parliament before it could be legalised, as mandated in the 2008 
Human Fertilisation and Embryology Act. The change in law was preceded by a 
lengthy process of inquiry including: scientific reviews (HFEA, 2014, 2016), a call 
for evidence on the ethical issues organised by the Nuffield Council on Bioethics 
(2012), public consultations (HFEA, 2013; DOH, 2014a) and government guidance 
on draft regulations led by the UK Department of Health (2014b). During the final 
debates of the Houses of Parliament, MPs in the House of Commons (2015) voted 
382 in favour of legalising the techniques with 120 against while the House of 
Lords (2015) voted 280 in favour with 48 against. Mitochondrial donation was 
legalised and the UK began the process of conducting the final safety checks and 
establishing a licencing procedure to regulate the first pregnancies.  
The UK was the first country to confirm a policy position on this issue, 
capitalising on the existing structures for regulating assisted conception 
technologies. The move was part of a broader UK project to continue the 
mobilisation of its highly regulated yet permissive human embryo research base, 
manifest in the work of the Human Fertilisation and Embryology Authority (HFEA) 
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(Lovell-Badge, 2008; Mikami and Stephens, 2016; Reubi, 2013). As such the 
mitochondrial donation debate can be mapped onto a historical lineage of public 
debates leading to early adoption of highly bureaucratic but essentially permissive 
regulatory forms on a set of embryology and assisted reproduction technologies 
beginning with IVF in the 1970s and 80s (Mulkay, 1993). More recent examples 
include human embryonic stem cells (Stephens, Atkinson and Glasner, 2008), 
hybrid embryos that combine human and animal material (Haran, 2013) and 
subsequent to the mitochondrial donation debates, human embryo research 
using gene editing techniques of CRISPR/cas9 (Authors). 
At the time of writing no child has been born in the UK through the newly 
legalised procedures and no clinics have yet been licenced. However, in 
September 2016 the New Scientist revealed that a child had been born through 
mitochondrial donation by a US team operating in Mexico (Hamzelou, 2016; 
Zhang et al. 2016) and that the techniques had also resulted in two pregnancies in 
the Ukraine (Coghlan, 2016). Neither Mexico nor Ukraine had formal legal 
positions on mitochondrial donation, just as neither had pursued a programme of 
scientific and ethical consultation on the topic, as seen in the UK. These 
announcements of the world’s first mitochondrial donation baby conceived in 
Mexico, and the Ukrainian pregnancies, highlight considerable differences in how 
reproductive medicine is practiced and regulated across the globe and situates 
the UK narratives reported here in a context of international innovation.  
In this article we apply a much needed sociological lens to this 
controversial technology and its regulatory biography in the UK through the social 
worlds framework (Clarke and Star, 2008). We first of all describe how the social 
worlds theory and methods package, and the concept of implicated actors, can be 
usefully applied to the mitochondrial debates. Secondly, we examine how 
mitochondrial donation draws upon a familiar set of metaphors and emotive 
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terminology often used to describe new genetic technologies and their social 
implications. This is followed by an extended section specifically focusing upon the 
immutable grammar of ‘three x x’ that formed a key component of the political 
debate. We focus on the politics of the ‘three x x’, its institutional use and its 
implicated and silenced beneficiaries. Finally we close with a discussion and 
conclusion about the nature of UK regulation within the global economy. 
 
Theory / methods package: the social worlds framework  
We draw on a social worlds framework to understand the journey of 
mitochondrial donation from bench towards bedside, reflecting a long tradition of 
application in the context of embryo politics and assisted reproduction (Clarke, 
1998; Ganchoff, 2004; Kitzinger et al., 2007; Timmermans and Shostak, 2016; 
Williams et al., 2008). The concept of social worlds was developed within the 
tradition of symbolic interactionism associated with pragmatism and the Chicago 
School of symbolic interactionism, and was initially described by Mead (1934) as a 
‘universe of discourse’. Social worlds are created through interaction, 
communication and negotiation. The framework is useful for highlighting how 
actors and groups can have different perspectives yet remain capable of working 
together, involving shared commitments, activities, materialities, work, 
performance and relationships (Clarke, 1997; Fujimura, 1992; Strauss 1978). Clark 
and Star (2008) linked several core ideas as ‘sensitising concepts’ (Blumer 1969) 
which can act as a guide for empirical analysis and form a conceptual tool box for 
theory building. Out of these, boundary objects is possibly the most recognisable 
and most frequently used to explain how objects can support co-operation 
between groups who otherwise experience an incommensurability of perspective, 
practice or language (Star and Griesemer, 1989). ‘Implicated actors’ is a less 
familiar concept, but it is useful for understanding political debates about new 
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technologies and is particularly relevant for this article. Clarke and Star (2008: 
119) highlight two kinds of implicated actors, those who are “physically present 
but are generally silenced/ignored/made invisible by those in power in the social 
world or arena” and those who are “not physically present in a given social world 
but solely discursively constructed and discursively present” [emphasis in 
original].  
Mitochondrial donation proves a valuable contemporary case study 
because it challenged both the UK legal framework and prevailing cultural 
assumptions about the symbolic and biological significance of genetic material. 
But the concept of ‘implicated actors’ is particularly relevant because of the 
novelty of the technology. The mitochondria donor, the intended mother with 
mitochondrial disease and the future child are all new actors who were 
introduced and discursively produced through the public and policy debates. This 
article explores how this group of implicated actors were “conceived, 
represented, and perhaps targeted by the work of arena participants” (Clarke and 
Star, 2008: 119). 
The social worlds framework also implies a methodological approach as 
part of its theory/methods package that draws upon the constructivist move in 
grounded theory (Clarke and Star, 2008; Charmaz, 2000, 2006). Grounded theory 
is a systematic approach to qualitative data analysis that can account for the 
complexity of social phenomena, allowing themes to emerge as the research 
progresses by constantly and consistently developing interpretations (Glaser & 
Strauss, 1967; Strauss and Corbin, 1998; Atkinson et al. 2003). We apply this to 
our analysis of a range of publically available documents, collected between 2012 
and 2015, at a time when mitochondrial donation received significant 
parliamentary and media attention.  
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The documents were collected in ‘real time’, as the events unfolded under 
the public gaze (Jaspal and Nerlich, 2016). All policy relevant documents produced 
by key UK institutional actors (primarily the Department of Health, the HFEA and 
Nuffield Council on Bioethics) between 2012 and 2015 were analysed. This 
included statements of remit, calls for evidence for consultation (and those 
contributions where they were available), published reports by these institutional 
actors on consultation conclusions, and any other related formal documents 
released. We also analysed Hansard transcripts of parliamentary debates in both 
UK Houses of Parliament. Outside of the key governmental actors we also 
analysed reports and outputs from key groups campaigning for legalisation (for 
example, Muscular Dystrophy UK and the Progress Educational Trust) and those 
opposed to legalisation (for example Christian Medical Fellowship and Human 
Genetics Alert). We also draw upon newspaper reporting of the events as the 
media was an important forum for the rapid communication of personal and 
professional viewpoints. We recognise our reference to media sources through 
purposive sampling serves as illustrative examples rather than constitute a 
systemised and exhaustive analysis of media outputs as found in more detailed 
cultural studies research. Although content analysis of newspaper coverage 
during the process of public debate would produce interesting insights, intensive 
and detailed media analysis is beyond the scope of this article. Instead, our 
attention to media coverage which also includes television, radio and online 
content (for example the Progress Educational Trust’s ‘Bionews’ archive of 
professional and expert views and commentary on genetics and assisted 
conception) forms one part of our real time following of the debate, alongside the 
extensive analysis of policy documents, parliamentary debates and institutional 
reports. Both authors analysed the data using thematic analysis, where themes 
emerged in real time as the political process progressed (Strauss and Corbin, 
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1998). Several key themes were identified including: the role of patients in the 
debates; discourses of hope and fear; histories and future imaginaries related to 
IVF technologies; national representations; risk; and appeals to expertise and 
evidence. In keeping with a grounded theory approach to generating thematic 
categories that span multiple years, the themes used were flexible and responsive 
to shifts in the data. For example data relating to patients was initially drawn from 
accounts of professionals who were speaking publically about or on behalf of 
patient groups. This theme later began to include more references to patients’ 
own accounts as increased numbers of patients actively spoke about themselves 
and their families. Our thematic categories evolved to include the engagement 
and activities of patients to ensure this important dynamic was captured. Overall 
the primary focus on the multiple metaphors and descriptors used to portray 
mitochondrial donation and the role of the mitochondrial donor was a direct 
response to the prominence of this theme in the analysis across all sections of the 
data corpus.  
 
Metaphors, meanings and mitochondrial donation 
The UK mitochondrial donation debate regularly drew upon metaphorical and 
emotive language. Analysing such discourse has a long history in medical 
sociology and science and technology studies in general (cf. Hellsten and Nerlich, 
2008; Hacking, 1999) and with reference to social worlds theory in particular (cf. 
Bowker and Star, 2000). Whereas Sontag (1979) highlighted how military 
metaphors– the body under attack and invaded – or the body as machine, are 
used to make sense of illness, the wider development and use of genetic 
technologies were accompanied by a new set of descriptive language. Computer 
metaphors and essentialist images enabled our genetic make-up to be described 
as a ‘code’, genes as part of the ‘book of life’ or a ‘blueprint’, with the quest to 
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map the human genome becoming the ‘holy grail’ (Nelkin, 2001). Metaphors can 
both constrain and facilitate our thinking (Nelson et al., 2015), and remain core 
topics for social science analysis.  
In some regards the UK mitochondrial debate draws upon this familiar set 
of representations which are now an entrenched repertoire for describing new 
technologies. Writing at the time when mitochondrial donation first became a 
possibility, Haran et al. (2008) documented some of the early metaphors used in 
the UK, including the 2004 Daily Mail heading ‘Science Seeks to Deliver a Baby 
with Three Parents’ and from 2005, ‘Designer Babies To Wipe Out Diseases 
Approved’ (Haran et al., 2008: 127). More than ten years later, the mitochondrial 
debates continue to feature such vivid imagery including: dystopian predictions 
about ‘slippery slopes’ and ‘crossing a line’ (Le Page, 2015); ‘designer babies’ 
(Hills, 2012); ‘Frankenstein science’ (McKie, 2014); and emotive themes such as 
‘playing god’ and stopping children suffering (Driscoll 2015).  
One example of a metaphor specific to the mitochondrial debates is the 
description of mitochondria as a ‘battery’. Jane Ellison MP, in her opening remarks 
at the House of Commons Debate, stated that ‘Mitochondria are present in 
almost every cell in the body and produce the energy we need to function. This is 
why they are often referred to as “the battery pack” of the cell.’ (Hansard, 3rd 
February 2015, column 160). Ellison went on to state that the techniques ‘are 
about replacing the battery pack that contains a small number of unhealthy genes 
with a healthy battery pack’ (column 161). Based on competing perspectives 
about the biological significance of mitochondrial DNA, the battery metaphor can 
be recognised as an accurate representation of complex science, an over 
simplification or a misrepresentation. Reducing the complexity of mitochondrial 
function enabled those supportive of legalisation to represent mitochondrial 
donation as the equivalent of ‘simply’ changing a laptop battery (Muir et al., 
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2015). In contrast the different analogy of comparing it to replacing one of the 
CPUs in a laptop might lead to a very different understanding of the contribution 
of the biological material to the child’s identity (Gemmell and Wolff, 2015).  
The mitochondria as battery metaphor reveals how language and 
representations matter, and that their use can be political. Representing 
mitochondria as a battery is an important component of the discourse 
surrounding mitochondrial donation, as it performs the important work of 
enabling the technology to be positioned as unproblematic. Further examples 
within the mitochondria debates include the cultural relevance and implications 
of describing the third person as donor or provider (Haimes and Taylor, 2015); 
whether the techniques should be classified as donation, transfer or replacement 
and whether it is appropriate to talk about reproductive technologies as a 
treatment or cure (Rulli, 2016). For the remainder of this paper we focus upon 
perhaps the most visible and contested metaphors used, the immutable grammar 
of the ‘three x x’. After introducing it and articulating its affordances in terms of 
the politics of genetic relatedness and kinship significance, we focus upon its 
denial in institutional reviews and the implicated actors it casts as beneficiaries 
and those beneficiaries distanced.  
 
Genetic parentage and the immutable grammar of ‘three x x’ 
As mitochondrial donation increasingly moved into the public gaze it was 
accompanied by a varied linguistic repertoire of terms referring to the 
mitochondrial donor as a ‘third person’ in one form or another (Ravitsky et al., 
2015). Mertes and Pennings (2008: 8), referring to the work of Robertson (1999), 
suggest ‘a major genetic mother’ and a ‘minor genetic mother’ as a way of 
distinguishing the intended mother from the mitochondrial donor. Other terms 
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include ‘mito mum’ (as reported in The Economist, 2014) and ‘shadow mum’ 
(McGee, 2012). However, none of these phrases attracted the profile of what we 
term the ‘three x x’ set which became a key trope around which genetic 
relatedness was contested during the period of the policy debate. This set of 
metaphors are a family of terms with multiple reconfigurations across what has 
become an immutable grammar of 'three x x'. It includes ‘three person IVF’, ‘three 
person DNA’, ‘three person babies’, ‘three person IVF’, ‘three-parent embryo’, 
‘three parent family’, ‘three parent children’ and ‘three-parent baby’. Applying 
the social worlds theory perspective to the actors implicated in the multiple 
variants of the ‘three x x’ grammar reveals multiple networks of kinship and 
genetic relatedness contested and enacted within the set. The first ‘x’ in the 
grammar is typically either ‘person’ or ‘parent’. ‘Three person’ variants imply less 
direct kinship and limited biological or social connectedness compared to ‘three 
parent’ variants. ‘Parent’ or ‘mother’ suggest more significance and relationality in 
the role of the third person – always understood to be the donor woman – to the 
family unit. The second ‘x’ typically denotes either the technique, biological 
material, the child or the child in a kinship context. We see all these as on a 
continuum that suggests the process of bringing into being a new life free of 
mitochondrial disease, but affording different notions of relationality to that life. 
At either end of this continuum, ‘three person IVF’ implies less relatedness and 
less kinship significance to the donor mother. In contrast, ‘three parent baby’ and 
‘three parent family’ both invoke strong biological, and possibly social, 
significance to the mitochondrial donor. 
It is possibly not surprising in the context of cultural privileging of genetic 
information, genetic identity and genetic parentage, that mitochondrial donation 
has become synonymous with ‘three parents’, at least in popular discourse. 
Representations of the ‘three parent’ family, along with various images of one 
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man, two women and a baby or child in different forms of embrace and 
configurations have dominated media stories for some time. In one example the 
BBC radio programme ‘Mum and Dad and Mum’, broadcast in February 2015, 
followed the story of a child born thirteen years previously through cytoplasm 
injection. This was a related technology which resulted in the birth of 17 children 
in 2000 in the US (Barritt et al., 2001)1. The radio programme was advertised with 
a striking image of four silhouettes, one behind each other at equal distance - a 
child, a woman, a man and then last in line, but remaining close, another female, 
presumably the mitochondrial donor. 
The strong imagery of the ‘three parent family’ and the language of the 
‘three parent baby’ has itself become the focus of public debate as well as the 
technology which they represent. The media have sometimes been blamed by 
pro-legalisation groups for putting a negative spin on the idea of the ‘three parent 
baby’ (Johnson, 2013). The role of the ‘three x x’ grammar as a political tool was 
noted during the debate and identified as potentially detrimental to garnering 
public support. Viscount Ridley in the Lords debate stated that the phrase was 
‘wildly misleading’ and the term three parents as a ‘misuse of the English 
language’ (House of Lords, 2015: 1587). Lord Robert Winston, renowned fertility 
expert and IVF pioneer wrote in his self-penned newspaper article (2015) that the 
‘three parent child’ idea was ‘nonsense’ and that it was used to court controversy 
before the parliamentary vote. Explicit attempts were subsequently made to 
encourage a move away from this term, including requests by prominent 
spokespeople at a public conference (Progress Education Trust Annual 
Conference, 2015), yet the term prevails in popular and political discourse.  
Throughout the debates, campaigners against legalisation continued to 
use the ‘three x x’ grammar and assert its appropriateness. Philippa Taylor of the 
Christian Medical Fellowship wrote in an information leaflet titled ‘three-parent 
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embryos for mitochondrial disorders’ that “the outcome of the technique is the 
creation of an embryo with two ‘mothers’ and one father” (2013). Like Taylor, 
Christian advocacy group CARE (2014) used a more kinship orientated variant of 
the ‘three x x’ set in their campaign materials, notably including statements such 
as “No other nation in the world has legalised the creation of three-parent 
children” in their commissioned survey of public attitudes (finding “just four per 
cent of those surveyed said they were more likely to support changing the law” 
based on this statement), and directing readers keen to support their campaign 
towards the no longer operative url www.stopgm3parentbabies.com. The 
affordance of discomfort in the ‘three x x’ set was also explicitly used as a strategy 
to discredit legalisation, for example Tim Stanley (2015), in the Telegraph 
newspaper, wrote: “‘Three parent babies.’ Run that phrase through your head. 
Doesn’t it sound a little wrong?... I would suggest... [y]our instinct is probably that 
‘three parent babies’ sounds like a step too far. Your instinct is entirely correct.” In 
all these cases the use of the kinship displaying variants of the ‘three x x’ asserts 
the moral and technical accuracy of emphasising the genetic relatedness of the 
egg donor to any progeny born. 
The ‘three x x’ grammar can be powerful for a number of reasons. Haran 
et al. (2008) highlighted how the ‘three parent baby’ threatens normative 
assumptions about society, as evidenced in headlines such as ‘Three-parent 
babies ‘threat to humanity’’ (The Sunday Times, 2014). Despite ever increasing 
possibilities of family forms (see for example, Franklin, 2013; Lock and Nguyen, 
2010) and a greater awareness of difference (Palacios-González et al., 2014), the 
spectre of the ‘three parents’ can seem ‘monstrous’ (Johnson, 2013), a danger to 
the ‘traditional’ nuclear family (Appleby and Karnein, 2014) and a threat to 
society. Thus the conceptualisation of, and metaphorical language surrounding 
the three contributors becomes much more symbolic than a question of biological 
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accuracy. The prominence of the ‘three x x’ language, as with the battery 
metaphor, suggests it has become an integral part of the ‘interpretive package’ 
(Gamson and Modigliani, 1989) of metaphors, images and justifications which give 
meaning to mitochondrial donation. The significance, and novelty, of the inclusion 
of a third person’s DNA, has meant that the ‘three x x’ set was unavoidable as an 
immutable grammar that became a vital vehicle for expression, or a problematic, 
which needed to be addressed whatever one believed about the role of the 
donor.  
 
Defining genetic parentage in institutional reviews  
The debate over the ‘three x x’ grammar was a recurrent theme of the 
institutional reviews supporting the public dialogue on mitochondrial donation. In 
2012 the Nuffield Council on Bioethics, in one of the first public calls for evidence 
about the ethical implications of the techniques, identified genetic relationships 
as a key issue. The Nuffield Council on Bioethics is the technically independent 
group who in practice come closest to a UK national bioethics committee in that 
they represent the UK at international meetings and broadly align with the 
politically dominant view in the UK on evidence-based scientific practice and the 
regulated permissibility of human embryo research (Jasanoff, 2005). Their 
consultation was based on a rapid response model to the emerging technology, 
creating the capacity for them to set the terms of the debate. In their call for 
evidence they asked: What might the use of these techniques signify for the 
relationships of the resulting child to the three adults with whom it shares a 
genetic connection? When subsequently reporting conclusions on the assembled 
submission to their call for evidence, internal hearings and discussion, the Nuffield 
Council on Bioethics (2012: xvi) declared “it is the view of the Working Group that 
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mitochondrial donation does not indicate, either biologically or legally, any notion 
of the child having either a ‘third parent’, or ‘second mother’”. 
The initial question and concluding statement are important for several 
reasons. Firstly, they highlight the possibility of genetic relatedness initiated by 
the introduction of a third genetic contributor. Secondly, they demonstrate how 
the role of the mitochondrial donor as parent or non-related donor is contestable, 
dependent on a particular perspective or ‘view’ rather than biological fact. Thirdly, 
they highlight the requirement to resolve the uncertainty surrounding the 
relationship between donor and child. This pattern of mentioning genetic 
relatedness but then ‘undoing’ kinship (Edwards, 2014) by ruling out the 
possibility of identifying the donor as a ‘parent’ remained a key feature of the 
government policy documents that we analysed.  
Another central institution of UK biomedical regulation, the Department 
of Health, conducted their own public consultation in an explicit attempt to move 
forward plans to legalise the technique under HFEA inspection (DoH, 2014a). The 
report also drew the conclusion that the mitochondrial donor was not a ‘second 
mother’ and regarded the term ‘three parent families’ as ‘completely 
inappropriate’. The report states: 
 
In using these techniques, the resulting child will have nuclear DNA (99.9 
per cent) from their father and mother and healthy mitochondrial DNA 
(0.1per cent) from a female donor. Genetically, the child will, indeed, have 
DNA from three individuals but all available scientific evidence indicates 
that the genes contributing to personal characteristics and traits come 
solely from the nuclear DNA, which will only come from the proposed 
child’s mother and father. The donated mitochondrial DNA will not affect 
those characteristics. (DoH, 2014b: 15) 
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Finally on institutional responses, in their document explaining the 
regulatory process around licencing mitochondrial donation, the HFEA stated: 
 
A key reason for encouraging clinics to disclose non-identifying donor 
information to patients and parents of donor-conceived people is to help 
parents share information about their child’s genetic origins, and to prepare 
them for potentially meeting their donor once they can receive donor 
identifying information at 18. These Regulations introduce a different 
system for mitochondrial donor-conceived children because it is recognised 
that a mitochondrial donor does not determine the characteristics of a child 
in the same way as with gamete donation and will not be the genetic parent 
of any child born. The Regulations specify that mitochondrial donors cannot 
be identified, reflecting the policy view that mitochondrial donation is more 
akin to organ donation than egg or sperm donation. (HFEA 16/09/2015: 47)  
 
While attempting to draw conclusions and thereby reduce the complexity 
of genetic relationships, this extract serves to highlight the ambiguity of genetic 
information in relation to the child and donor. Significantly, while the regulations 
around mitochondrial donation declare that the donor is not a genetic parent, it 
remains possible that the child might want to have information about the 
mitochondrial donor if it concerns ‘their genetic origins’. This reveals the social 
significance of genetic relatedness as a strong cultural influence. Yet it also reveals 
how mitochondrial donation disrupts established classificatory systems and legal 
frameworks around reproductive technologies; both the child and the 
mitochondrial donor are positioned in relation to a technology that is 
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ambiguously represented as similar to both solid organ and gamete donation, but 
not the same. 
 
Implicated actors invoked as beneficiaries  
Those supporting the legalisation of the techniques, and typically denying 
the relevance of all but the least kinship orientated variants of the ‘three x x’ 
grammar, articulated a clear set of beneficiaries from the legalisation: families 
with a mother carrying mitochondrial disease and their as yet unborn progeny. 
Women currently carrying mitochondrial mutations, and thus at risk of giving 
birth to children who may have mitochondrial disease, were physically present 
and highly visible in the public debates. Their emotionally powerful stories, 
particularly around the devastating effects of severe disease on a child, were used 
as evidence in support of the techniques and enabled this group to be projected 
as future beneficiaries of the technologies. In addition to producing healthy 
children, one of the points of persuasion in the mitochondrial debate is that 
despite alternative reproductive options, including egg donation, mitochondrial 
donation offers these women the opportunity to have their own, genetically 
related children. This was highlighted as one of the key arguments in favour of 
supporting the techniques, as mentioned in the opening speech of the House of 
Lords debate:  
 
The techniques provided for by these regulations offer the only hope for 
some women who carry the disease to have healthy, genetically related 
children who will not suffer from the devastating and often fatal 
consequences of serious mitochondrial disease. (The Parliamentary Under-
Secretary of State for Health, Earl Howe, House of Lords, February 2015: 
column 1569) 
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This is a succinct account of why the techniques might be supported, with 
the possibility of a genetically related child alongside offering reproductive hope 
and a child in good health. The actors involved are the mothers carrying 
mitochondrial mutations and the entirely implicated and as-yet unborn children of 
these mothers who would live without mitochondrial disease or risk of 
transferring it to their own children. In the presentation of these techniques as a 
public good, genetic relatedness of the mother to her child is prioritised: we 
celebrate because the child is her biological progeny free from mitochondrial 
disease, as opposed to a child free from mitochondrial disease and brought into 
the family through adoption, for example. However, there is a discrepancy in how 
those contributing to the debates valued genetic relatedness and in the next 
section we ask for whom genetic relatedness is rendered important and how 
other potential beneficiaries of the technologies were positioned.  
 
Actors rendered distant and beneficiaries denied 
For those supporting legalisation the genetic relatedness of the mother 
was positioned as central to the benefit of the technique, while in contrast the 
genetic relatedness of the donor woman was distanced, in part through denying 
the ‘three x x’ grammar or using kinship reducing variants like ‘three person IVF’. 
The donor woman is an example of Clarke and Star’s (2008) second type of 
implicated actor: discursively constructed and represented in the debate by the 
voice of others. At the time of the debates donor women did exist in the UK but 
their kinship relation to a child was not yet a lived issue: their eggs had only been 
used in experimental procedures to produce embryos for research that were 
destroyed and were not implanted into a womb (Craven et al., 2010). This given, 
donor women did not personally feature in the public debates, but instead as 
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implicated actors were spoken for by others. Haimes and Taylor (2015) highlight 
how the donor had become an absent presence, where her role was minimised, 
distanced and rendered invisible as part of a political strategy. They suggest one 
layer to this is the terminology of ‘mitochondrial donor’, which implied that it was 
only mitochondria she provided, rather than the other cellular structures in the 
egg.  
We suggest that positioning the mitochondria as a battery also performs 
this work of underplaying the social meaning of the donor’s genetic contribution. 
The replicability, and with it disposability, of a battery that only powers, but does 
not alter the form of that which it powers, creates a disconnect between 
mitochondrial DNA and the identity of the child, just as the choice of the ‘x’ in the 
‘three x x’ grammar configures the donor as parent or person. According to UK 
law now in place, even though she donates an egg she is not considered an egg 
donor; and even though her genes will be passed on to the child and future 
generations, she is not considered a parent.  
There are another set of implicated actors who were distanced from the 
debate by those supporting the techniques. In the UK, mitochondrial donation will 
legally be available only to those at risk of having a child with mitochondrial 
disease, meaning that other user groups who could benefit from the potential of 
mitochondrial genetic relatedness could not be configured as future users or 
beneficiaries. For example, mitochondrial donation could be a way for a lesbian 
couple to have a child who is genetically related to both parties (one contributing 
nuclear DNA, the other contributing mitochondrial DNA). Older woman with lower 
levels of fertility are another group who have been ruled out as potential 
beneficiaries. Mitochondrial donation might improve their chances of having a 
child (as reported in Smyth, 2015) and would be a clear successor to cytoplasm 
injection (mentioned previously) which was initially designed to combat infertility. 
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Thus older and lesbian women who had the potential to contribute to the debate, 
were implicated, but silenced, by being positioned outside the realm of noted 
beneficiaries. While the internal relationships of the ‘three’ in the ‘three x x’ was 
frequently debated and contested, the fact that the three did not include a 
lesbian couple or an older women seeking fertility treatment was not a prominent 
feature. 
 
Discussion and conclusion 
The legalisation of mitochondrial donation represents a significant moment in UK 
biomedical political history. In this article we have focused on the discussions 
which took place in the UK prior to the change in law. The debates brought 
different kinds of genetic material into the public imagination. The introduction of 
a third genetic contributor in collaborative reproduction confronts our 
understanding of the biological and social significance of genetic material and 
genetic relatedness. Categorising genetic material on the basis of form, function 
and location has challenged previous ideas about the primacy of the gene as a 
‘cultural icon’ (Nelkin and Lindee, 1995).  
The social worlds theory provides an important framework to extend our 
analysis. The public debates about mitochondrial donation have been an 
inherently political process, legitimising particular kinds of discourse (for example, 
mitochondria as a battery; and the mitochondrial donor as a ‘third’ person) and 
implicating certain groups of people as natural beneficiaries (women at risk of 
having a child with mitochondrial disease). Social worlds theory also recognises 
the importance of context, which is particularly important for examining scientific 
controversies and newly emerging technologies (Clarke and Star, 2008). We have 
shown that the biography of mitochondrial donation and its journey from bench 
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towards bedside via public consultations and parliamentary debates can only be 
situated within the current political, cultural and social context.  
Importantly, social worlds theory recognises the power of collective 
action, in order ‘to get work done and to produce relatively (and temporarily) 
stable facts’ (Fujimura, 1992: 168). Members of the social world who supported 
mitochondrial techniques shared a common goal (the legalisation of 
mitochondrial donation) where their primary activities involved the emotional and 
practical work of persuading others of its value (Strauss 1978). The overwhelming 
majority vote in favour of legalising the technologies in the Houses of Parliament 
attests to the success of this work; a group of scientists, parents and policy 
makers who were able to persuade others of the future value of mitochondrial 
donation. One of the reasons for their success was that they were able to draw 
upon cultural priorities of health and genetic relationships. The dominant 
representation of mitochondrial donation was as a technological solution for 
children and families and this offered a collective and powerful vision of hope 
(Mulkay, 1993; Novas, 2006).  
A remarkable feature of the mitochondrial debates within the UK was that 
there has been little room for exploring the wider significance of the terminology 
in use and it has featured minimal talk about progression and wider benefits of 
the developing science. In fact it was the opposite, and unusually for a novel 
technology, part of its promise (within the UK) was that its use would be 
restricted to a defined population and that it would remain closely controlled and 
regulated.  
Despite there being potentially expansive uses for different groups of 
people, mitochondrial donation was presented as a restricted technology that 
would only benefit a specific group of patients defined through their health status 
and reproductive risk. Those with the power to concentrate the discourse upon 
23 
 
the disease state of heterosexual families with mitochondrial disease were able to 
render others invisible. Despite having the potential to be discussed as a 
transformative technology, in many ways the terms of the mitochondrial debates 
and the conclusions of key UK institutions remained within conservative 
boundaries.  
The UK decision to legalise the two techniques of maternal spindle 
transfer and pro-nuclear transfer could have global implications (Ishii, 2014) and 
debates are currently happening alongside gene editing in the US and elsewhere 
(Rulli, 2016). But it is now clear that although the UK was celebrated as the first to 
legalise mitochondrial donation, two important moments in the mitochondrial 
donation timeline might also prove to have a significant impact on its future 
global trajectory. While scientists in the UK were conducting further experiments 
to satisfy the requirements of the HFEA, a US team delivered a baby boy born via 
maternal spindle techniques, circumventing the as yet unresolved US legal 
position by conducting the procedure in Mexico. And while the UK has restricted 
use to only those at risk of mitochondrial disease, the two pregnancies in the 
Ukraine resulted from the techniques used by women with fertility issues rather 
than those at risk of passing on an inherited condition. If these pregnancies result 
in healthy babies, then we might witness a potentially large and powerful 
population initiate their contribution to the debate by demanding access to the 
technology within or outside UK boundaries. This could lead to more expansive 
debates about the social value of the technology, paralleling those currently 
taking place about social egg freezing for example, where the focus is on freezing 
eggs for social reasons such as a lifestyle choice rather than health reasons (see 
for example, Baldwin et al., 2014).  
Overall this article has highlighted why mitochondrial donation and its 
related debates are sociologically interesting. Greater attention to the political 
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nature of science debates, the context in which they take place and how social 
worlds operate as powerful collectives can help us understand the different logics 
at play. Following the unexpected announcement of the birth of the first baby and 
with the new technology of gene editing also on the horizon (Nuffield Council on 
Bioethics, 2016), it is important that social science researchers are in a position to 
respond to these challenges and opportunities. 
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1 Whereas mitochondrial donation involves the transfer of the nucleus into an 
enucleated donated egg, this previous technology injected cytoplasm from the 
donated egg (which contained healthy mitochondria), in the hope that the healthy 
mitochondria would out-perform the faulty mitochondria. The children born were 
not enrolled in any kind of follow up study and the technique was subsequently 
discouraged by the FDA (Food and Drug Administration) due to fears about safety. 
